NCT05269199已完成不适用
Sexual Health Impact of Using Pre-exposure HIV Prophylaxis
University Hospital, Clermont-Ferrand7 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2022年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 56
- 试验地点
- 7
- 主要终点
- Sexual health satisfaction
研究概览
简要总结
Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).
详细描述
This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription.
- •Able to give his non-opposition to participate in the research.
- •Affiliation to a social security scheme.
排除标准
- •Patient under curatorship/guardianship or safeguard of justice
- •Refusal to participate
结局指标
主要结局
Sexual health satisfaction
时间窗: 1 day during the scheduled consultation
To study the sexual health satisfaction of men who have sex with men (MSM), since the use of HIV prophylaxis by pre-exposure treatment (PrEP), compared to the time before PrEP.
次要结局
- Sentimental satisfaction(1 day during the scheduled consultation)
- Risky behaviours(1 day during the scheduled consultation)
- Specific care(1 day during the scheduled consultation)
- Predictors of satisfaction(1 day during the scheduled consultation)
研究者
研究点 (7)
Loading locations...
相似试验
已完成
不适用
Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) ClinicsHIV InfectionsNCT01632995National Institute of Allergy and Infectious Diseases (NIAID)557
已完成
不适用
Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence StudyRisk ReductionRisk BehaviorHIV InfectionsRisky Health BehaviorSTDHIV SeropositivityHIV Infection PrimaryNCT05674682Evandro Chagas National Institute of Infectious Disease4,000
已完成
不适用
Pre-exposure Prophylaxis: A Miracle Drug or a Moral HazardChlamydiaGonorrheaSyphilisSexually Transmitted DiseasesNCT04325555New York University2,647
Unknown
不适用
PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and ImplementationHIV InfectionsNCT03253757St Stephens Aids Trust10,000
已完成
1 期
Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in WomenHIVNCT01749566Emory University31